AkzoNobel-Axalta review in final stages; remedies limited to US and EU, CEO says
By Flavia Fortes ( October 21, 2026, 11:27 GMT | Insight) -- AkzoNobel’s merger with Axalta is approaching the final stages of regulatory review, with planned business sales in the US and Europe the only remedies sought by competition authorities, AkzoNobel chief executive Greg Poux-Guillaume said on Wednesday.AkzoNobel’s merger with Axalta is approaching the final stages of regulatory review, with planned business sales in the US and Europe the only remedies sought by competition authorities, the chief executive of AkzoNobel said on Wednesday....
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.